generic
Allergan files ANDA for generic version of Celgene’s breast cancer treatment
March 18, 2016Business Services, Medical Communications, Sales and Marketing Abraxane, Allergan, Celgene, breast cancer, generic
Allergan (NYSE: AGN) said it is seeking regulatory approval for a generic version of biotech firm Celgene’s (Nasdaq: CELG) breast …
FDA grants approval for first generic version of Viagra
March 10, 2016Manufacturing and Production, Research and Development, Sales and Marketing FDA, Pfizer, Teva, erectile dysfunction, generic, viagra
The US Food and Drug Administration (FDA) has granted approval to the first generic version of Pfizer’s blockbuster erectile dysfunction …
Teva faces $512m fine in generic Provigil row
April 22, 2015Sales and Marketing Cephalon, Mylan, Teva, generic, modafinil, provigil
Teva has agreed to a record $512 million settlement in a ‘pay-to-delay’ row over generic versions of its drug Provigil. …
Lundbeck sales slide as generic competition bites
November 6, 2014Sales and Marketing Ebixa, Lundbeck, Q3, Xenazine, generic, onfi, sabril
Lundbeck’s sales fell dramatically in the third quarter of 2014 as it struggles with expiring patents, although several of its …
Generic Actos gains FDA approval
August 20, 2012Sales and Marketing Actos, Mylan, Ranbaxy, Takeda, diabetes, generic
Takeda’s big-selling diabetes pill Actos will have its US sales decimated after the FDA approves three copycat versions of the …
NHS spending on drugs fell in 2011
April 4, 2012Sales and Marketing NHS, cost savings, generic, patent, prescriptions, spend
The NHS in England spent less on its drugs budget last year, bucking the longstanding upward trend. This is because …
Watson submits Crestor copycat
October 28, 2010Sales and Marketing AstraZeneca, Crestor, Watson, generic, patent
Watson Pharmaceuticals is seeking to launch a generic version of AstraZeneca cholesterol blockbuster Crestor, exploiting weaknesses in its patent. The …
Latest content
FibroFind appoints Lee Borthwick as CEO
